Importer of Controlled Substances; Notice of Registration, 36694 [2010-15556]
Download as PDF
<![CDATA[
36694
Federal Register / Vol. 75, No. 123 / Monday, June 28, 2010 / Notices
research facilities for drug testing and
analysis.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Sigma Aldrich Manufacturing LLC. to
import the basic classes of controlled
substances is consistent with the public
interest, and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971, at this time. DEA has
investigated Sigma Aldrich
Manufacturing LLC. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated December 17, 2009,
and published in the Federal Register
on January 4, 2010 (75 FR 160), Mylan
Technologies Inc., 110 Lake Street, Saint
Albans, Vermont 05478, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
schedule II:
Schedule
jlentini on DSKJ8SOYB1PROD with NOTICES
II
II
The company plans to import the
listed controlled substances for
analytical research and clinical trials.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Mylan Technologies Inc. to import the
basic classes of controlled substances is
21:02 Jun 25, 2010
Jkt 220001
BILLING CODE 4410–09–P
Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–15555 Filed 6–25–10; 8:45 am]
BILLING CODE 4410–09–P
Importer of Controlled Substances;
Notice of Registration
DEPARTMENT OF JUSTICE
VerDate Mar<15>2010
[FR Doc. 2010–15556 Filed 6–25–10; 8:45 am]
Meridian Medical Technologies to
import the basic classes of controlled
substances is consistent with the public
interest, and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971, at this time. DEA has
investigated Meridian Medical
Technologies to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and § 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Drug Enforcement Administration
BILLING CODE 4410–09–P
Methylphenidate (1724) ...............
Fentanyl (9801) ...........................
Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
DEPARTMENT OF JUSTICE
[FR Doc. 2010–15557 Filed 6–25–10; 8:45 am]
Drug
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated Mylan
Technologies Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
By Notice dated March 16, 2010, and
published in the Federal Register on
March 24, 2010 (75 FR 14187), Meridian
Medical Technologies, 2555 Hermelin
Drive, St. Louis, Missouri 63144, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of
Morphine (9300), a basic class of
controlled substance listed in schedule
II.
The company manufactures a product
containing morphine in the United
States. The company exports this
product to customers around the world,
including in Europe. The company has
been asked to ensure that its product
sold to European customers meets
standards established by the European
Pharmacopeia, which is administered
by the Directorate for the Quality of
Medicines (EDQM). In order to ensure
that its product will meet European
specifications, the company seeks to
import morphine supplied by EDQM to
use as reference standards. This is the
sole purpose for which the company
will be authorized by DEA to import
morphine.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated March 16, 2010, and
published in the Federal Register on
March 24, 2010 (75 FR 14186), Roche
Diagnostics Operations Inc., Attn:
Regulatory Compliance, 9115 Hague
Road, Indianapolis, Indiana 46250,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
the basic classes of controlled
substances listed in schedules I and II:
Drug
Lysergic acid diethylamide (7315)
Tetrahydrocannabinols (7370) ....
Alphamethadol (9605) .................
Cocaine (9041) ............................
Ecgonine (9180) ..........................
Methadone (9250) .......................
Morphine (9300) ..........................
Schedule
I
I
I
II
II
II
II
The company plans to import the
listed controlled substances for the
manufacture of diagnostic products for
distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Roche Diagnostics Operations Inc. to
E:\FR\FM\28JNN1.SGM
28JNN1
]]>Agencies
[Federal Register Volume 75, Number 123 (Monday, June 28, 2010)]
[Notices]
[Page 36694]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-15556]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated December 17, 2009, and published in the Federal
Register on January 4, 2010 (75 FR 160), Mylan Technologies Inc., 110
Lake Street, Saint Albans, Vermont 05478, made application by renewal
to the Drug Enforcement Administration (DEA) to be registered as an
importer of the basic classes of controlled substances listed in
schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Methylphenidate (1724)..................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
analytical research and clinical trials.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the
registration of Mylan Technologies Inc. to import the basic classes of
controlled substances is consistent with the public interest, and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has investigated
Mylan Technologies Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34,
the above named company is granted registration as an importer of the
basic classes of controlled substances listed.
Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-15556 Filed 6-25-10; 8:45 am]
BILLING CODE 4410-09-P
